BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 17403173)

  • 1. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
    Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
    Righetti M; Serbelloni P; Milani S; Ferrario G
    Blood Purif; 2006; 24(4):379-86. PubMed ID: 16755160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial.
    Zoungas S; McGrath BP; Branley P; Kerr PG; Muske C; Wolfe R; Atkins RC; Nicholls K; Fraenkel M; Hutchison BG; Walker R; McNeil JJ
    J Am Coll Cardiol; 2006 Mar; 47(6):1108-16. PubMed ID: 16545638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation.
    Huemer M; Ausserer B; Graninger G; Hubmann M; Huemer C; Schlachter K; Tscharre A; Ulmer H; Simma B
    Epilepsia; 2005 Oct; 46(10):1677-83. PubMed ID: 16190942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients.
    Righetti M; Ferrario GM; Milani S; Serbelloni P; La Rosa L; Uccellini M; Sessa A
    Med Sci Monit; 2003 Apr; 9(4):PI19-24. PubMed ID: 12709680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.
    House AA; Eliasziw M; Urquhart BL; Freeman DJ; Spence JD
    Am J Kidney Dis; 2004 Oct; 44(4):689-94. PubMed ID: 15384020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
    J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.
    Heinz J; Kropf S; Domröse U; Westphal S; Borucki K; Luley C; Neumann KH; Dierkes J
    Circulation; 2010 Mar; 121(12):1432-8. PubMed ID: 20231532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
    Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
    Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
    Morgan SL; Baggott JE; Lee JY; Alarcón GS
    J Rheumatol; 1998 Mar; 25(3):441-6. PubMed ID: 9517760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure.
    Bernasconi AR; Liste A; Del Pino N; Rosa Diez GJ; Heguilén RM
    Nephrology (Carlton); 2006 Apr; 11(2):137-41. PubMed ID: 16669976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients.
    Marcucci R; Zanazzi M; Bertoni E; Rosati A; Fedi S; Lenti M; Prisco D; Castellani S; Abbate R; Salvadori M
    Transplantation; 2003 May; 75(9):1551-5. PubMed ID: 12792513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial.
    Ossareh S; Shayan-Moghaddam H; Salimi A; Asgari M; Farrokhi F
    Iran J Kidney Dis; 2009 Oct; 3(4):227-33. PubMed ID: 19841527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
    Green TJ; Skeaff CM; McMahon JA; Venn BJ; Williams SM; Devlin AM; Innis SM
    Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial.
    Venn BJ; Mann JI; Williams SM; Riddell LJ; Chisholm A; Harper MJ; Aitken W; Rossaak JI
    Eur J Clin Nutr; 2002 Aug; 56(8):748-54. PubMed ID: 12122551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.